Mark J Magera

Title: The Innovative Journey of Mark J. Magera in Patent Development

Introduction

Mark J. Magera is a notable inventor based in Rochester, Minnesota. With a focus on enhancing medical research and diagnostics, he holds two significant patents that contribute to the field of pharmacogenomics.

Latest Patents

Mark's latest inventions are centered around the determination of thiopurine methyltransferase (TPMT) activity. The first patent, titled "Kit for rapid determination of thiopurine methyltransferase activity," outlines methods and materials for the quick, quantitative assessment of TPMT activity in biological samples. This innovative kit is crucial for understanding individual responses to thiopurine medications. The second patent, "Method for rapid determination of thiopurine methyltransferase activity," complements the first by detailing the methodologies necessary for the same rapid assessment, along with compositions and kits useful for this analytical task.

Career Highlights

Mark J. Magera is associated with the Mayo Foundation for Medical Education and Research, a renowned institution committed to advancing medical knowledge and patient care. His work at Mayo focuses on integrating research into practical clinical applications, making substantial contributions to the field of personalized medicine.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues such as John F. O'Brien and Jean M. Lacey. These partnerships have played a pivotal role in the development and refinement of his patents, showcasing the importance of teamwork in the realm of innovation.

Conclusion

Mark J. Magera's contributions to the medical field through his patents on TPMT activity determination reflect a commitment to enhancing healthcare diagnostics. His collaborations and association with the Mayo Foundation for Medical Education and Research position him as a significant figure in the landscape of innovation in medicine.